A 34-year-old woman (gravida 3, para 2) at 16 weeks’ gestation was found to have platelets unable to be quantified because of clumping on routine prenatal blood work, with a visual estimate of 40 ...
The Telegraph on MSN
Bruises send Wood River mom rushing her 3-year-old to St. Louis Children’s Hospital
Wood River 3-year-old diagnosed with rare autoimmune disease after sudden bruising ...
But which numbers actually matter? Routine blood tests remain among the most important ways to track overall health, yet most people never learn what values physicians prioritize. Understanding key ...
Telangana Excise Constable Gajula Sowmya, attacked by Ganja smugglers, shows slight improvement but remains in critical condition at NIMS, Hyderabad.
Miami, FL / Syndication Cloud / January 23, 2026 / Kure Care a division of Veracor Group LLC Key Takeaways Approximately 6.5 to 6.7 million people in the U.S. are affected by chronic wounds each year, ...
MedPage Today on MSNOpinion
Let's rethink how EHRs flag 'abnormal' lab results
Portal designs often amplify alarm rather than offering context ...
A new benchtop hematology system combines complete blood count, 5-part leukocyte differential, and rapid CRP testing from a single small blood sample, enabling faster detection of infection and ...
DARZALEX FASPRO ® U.S. Prescribing Information. 2 Johnson & Johnson Innovative Medicine. DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet ...
20don MSN
The Truth About Hair Transplants
Trust us—you know a guy or two who’s had this procedure, even if they won’t admit it. Here’s what they know that you don’t.
According to results from the IMerge trial, 2 39.8% of patients treated with imetelstat achieved 8 weeks of transfusion independence compared with 15.0% of patients treated with placebo. Respondents ...
Sanofi (NASDAQ:SNY) is one of the best blue-chip stocks to buy for 2026. On January 5, the US Food and Drug Administration announced the approval of Sanofi SA (NASDAQ:SNY)’s Cablivi. The approval ...
Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today provided a business update, including providing preliminary unaudited 2025 revenue estimates and raising full year 2026 and multi-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results